Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Kat14 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KAT14 mRNA | CTD | PMID:22079256 | Kat14 | Rat | 1,2-dichloroethane | increases expression | ISO | Kat14 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of KAT14 mRNA | CTD | PMID:28960355 | Kat14 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Kat14 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KAT14 mRNA | CTD | PMID:22206623 | Kat14 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Kat14 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of KAT14 mRNA | CTD | PMID:22206623 | Kat14 | Rat | 1,3,5-trinitro-1,3,5-triazinane | decreases expression | EXP | | 6480464 | cyclonite results in decreased expression of KAT14 mRNA | CTD | PMID:25559034 | Kat14 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of KAT14 mRNA | CTD | PMID:30723492 | Kat14 | Rat | 17beta-estradiol | increases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Estradiol results in increased expression of KAT14 mRNA | CTD | PMID:16474171 | Kat14 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Kat14 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Kat14 | Rat | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Kat14 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Kat14 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Kat14 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of KAT14 mRNA | CTD | PMID:21570461 | Kat14 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of KAT14 mRNA | CTD | PMID:21346803 | Kat14 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of KAT14 mRNA | CTD | PMID:21346803 | Kat14 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of KAT14 mRNA | CTD | PMID:30851411 | Kat14 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KAT14 mRNA | CTD | PMID:28628672 | Kat14 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of KAT14 mRNA | CTD | PMID:30779732 | Kat14 | Rat | aristolochic acid A | increases expression | ISO | KAT14 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of KAT14 mRNA | CTD | PMID:33212167 | Kat14 | Rat | arsenite(3-) | increases methylation | ISO | KAT14 (Homo sapiens) | 6480464 | arsenite results in increased methylation of KAT14 promoter | CTD | PMID:23974009 | Kat14 | Rat | benzo[a]pyrene | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of KAT14 mRNA | CTD | PMID:32234424 | Kat14 | Rat | beta-lapachone | increases expression | ISO | KAT14 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of KAT14 mRNA | CTD | PMID:38218311 | Kat14 | Rat | beta-lapachone | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of KAT14 mRNA | CTD | PMID:38218311 | Kat14 | Rat | bisphenol A | increases expression | ISO | KAT14 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of KAT14 mRNA | CTD | PMID:16474171 and PMID:25912373 | Kat14 | Rat | bisphenol A | decreases methylation | ISO | Kat14 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of KAT14 promoter | CTD | PMID:27312807 | Kat14 | Rat | bisphenol A | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KAT14 mRNA | CTD | PMID:28628672 | Kat14 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of KAT14 gene | CTD | PMID:28505145 | Kat14 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of KAT14 mRNA | CTD | PMID:25181051 | Kat14 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of KAT14 mRNA | CTD | PMID:30816183 more ... | Kat14 | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of KAT14 mRNA | CTD | PMID:19167457 | Kat14 | Rat | carbon nanotube | increases expression | ISO | Kat14 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of KAT14 mRNA | CTD | PMID:25554681 | Kat14 | Rat | CGP 52608 | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to KAT14 gene] | CTD | PMID:28238834 | Kat14 | Rat | chlorpyrifos | decreases expression | ISO | Kat14 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of KAT14 mRNA | CTD | PMID:32715474 | Kat14 | Rat | chrysene | increases expression | ISO | Kat14 (Mus musculus) | 6480464 | chrysene results in increased expression of KAT14 mRNA | CTD | PMID:26377693 | Kat14 | Rat | cisplatin | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of KAT14 mRNA | CTD | PMID:27392435 | Kat14 | Rat | copper(II) sulfate | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of KAT14 mRNA | CTD | PMID:19549813 | Kat14 | Rat | crocidolite asbestos | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of KAT14 mRNA | CTD | PMID:18687144 | Kat14 | Rat | cyclosporin A | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of KAT14 mRNA | CTD | PMID:20106945 and PMID:25562108 | Kat14 | Rat | dexamethasone | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KAT14 mRNA | CTD | PMID:28628672 | Kat14 | Rat | Dibutyl phosphate | affects expression | ISO | KAT14 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of KAT14 mRNA | CTD | PMID:37042841 | Kat14 | Rat | dorsomorphin | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Kat14 | Rat | doxorubicin | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of KAT14 mRNA | CTD | PMID:29803840 | Kat14 | Rat | ethanol | affects splicing | ISO | Kat14 (Mus musculus) | 6480464 | Ethanol affects the splicing of KAT14 mRNA | CTD | PMID:30319688 | Kat14 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of KAT14 mRNA | CTD | PMID:24136188 | Kat14 | Rat | folic acid | multiple interactions | ISO | Kat14 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KAT14 mRNA | CTD | PMID:22206623 | Kat14 | Rat | formaldehyde | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of KAT14 mRNA | CTD | PMID:20655997 | Kat14 | Rat | FR900359 | increases phosphorylation | ISO | KAT14 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of KAT14 protein | CTD | PMID:37730182 | Kat14 | Rat | genistein | increases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Genistein results in increased expression of KAT14 mRNA | CTD | PMID:16474171 | Kat14 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of KAT14 mRNA | CTD | PMID:33387578 | Kat14 | Rat | hydrogen peroxide | affects expression | ISO | KAT14 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of KAT14 mRNA | CTD | PMID:20044591 | Kat14 | Rat | hydrogen peroxide | increases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of KAT14 mRNA | CTD | PMID:18951874 | Kat14 | Rat | indometacin | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KAT14 mRNA | CTD | PMID:28628672 | Kat14 | Rat | iron dichloride | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of KAT14 mRNA | CTD | PMID:35984750 | Kat14 | Rat | methylmercury chloride | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of KAT14 mRNA | CTD | PMID:28001369 | Kat14 | Rat | nickel sulfate | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of KAT14 mRNA | CTD | PMID:22714537 | Kat14 | Rat | ochratoxin A | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of KAT14 mRNA | CTD | PMID:22124623 | Kat14 | Rat | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of KAT14 mRNA | CTD | PMID:22124623 | Kat14 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT14 mRNA | CTD | PMID:27188386 | Kat14 | Rat | paracetamol | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of KAT14 mRNA | CTD | PMID:21420995 | Kat14 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of KAT14 mRNA | CTD | PMID:33387578 | Kat14 | Rat | paracetamol | affects expression | ISO | Kat14 (Mus musculus) | 6480464 | Acetaminophen affects the expression of KAT14 mRNA | CTD | PMID:17562736 | Kat14 | Rat | PCB138 | multiple interactions | ISO | Kat14 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Kat14 | Rat | pentachlorophenol | increases expression | ISO | Kat14 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of KAT14 mRNA | CTD | PMID:23892564 | Kat14 | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | Kat14 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of KAT14 mRNA | CTD | PMID:37995155 | Kat14 | Rat | phenobarbital | affects expression | ISO | KAT14 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of KAT14 mRNA | CTD | PMID:19159669 | Kat14 | Rat | pirinixic acid | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KAT14 mRNA | CTD | PMID:19710929 | Kat14 | Rat | potassium chromate | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KAT14 mRNA | CTD | PMID:22079256 | Kat14 | Rat | potassium chromate | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of KAT14 mRNA | CTD | PMID:22079256 | Kat14 | Rat | rac-lactic acid | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of KAT14 mRNA | CTD | PMID:30851411 | Kat14 | Rat | SB 431542 | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Kat14 | Rat | sodium arsenite | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of KAT14 mRNA | CTD | PMID:22714537 more ... | Kat14 | Rat | sodium fluoride | decreases expression | ISO | Kat14 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of KAT14 mRNA | CTD | PMID:27862939 | Kat14 | Rat | succimer | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KAT14 mRNA | CTD | PMID:26378955 | Kat14 | Rat | temozolomide | increases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of KAT14 mRNA | CTD | PMID:31758290 | Kat14 | Rat | thiram | decreases expression | ISO | KAT14 (Homo sapiens) | 6480464 | Thiram results in decreased expression of KAT14 mRNA | CTD | PMID:38568856 | Kat14 | Rat | titanium dioxide | decreases methylation | ISO | Kat14 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of KAT14 gene | CTD | PMID:35295148 | Kat14 | Rat | triphenyl phosphate | affects expression | ISO | KAT14 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of KAT14 mRNA | CTD | PMID:37042841 | Kat14 | Rat | valproic acid | multiple interactions | ISO | KAT14 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT14 mRNA | CTD | PMID:27188386 | |